Thermo Fisher Scientific SARS Coronavirus Spike Protein Recombinant Mouse Monoclonal Antibody (17F706R)

Applications

Tested Dilution

Publications

Western Blot (WB)

0.5-2.0 µg/mL

-

Product Specifications

Species Reactivity

Virus

Host/Isotype

Mouse / IgG1

Expression System

HEK293 cells

Class

Recombinant Monoclonal

Type

Antibody

Clone

17F706R

Immunogen

Synthetic peptide corresponding to residues 1124-1140 of human SARS-Spike protein.

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

1.0 mg/mL

Purification

Antigen affinity chromatography

Storage buffer

PBS

Contains

0.02% sodium azide

Storage conditions

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Shipping conditions

Ambient (domestic); Wet ice (international)

RRID

AB_1087213

Product Specific Information

The immunogen is 100% (16/16) homologous to SARS-COV-2 (COVID-19) Spike protein. The cross reactivity is not empirically tested.

This is the mouse recombinant monoclonal version of the clone 17F706 produced from mouse ascites.

Target Information

It has recently been shown that SARS (severe acute respiratory syndrome) is caused by a human coronavirus. Human coronaviruses are the major cause of upper respiratory tract illness, such as the common cold, in humans. Coronaviruses are positive-stranded RNA viruses, featuring the largest viral RNA genomes known to date (27-31 kb). The first step in coronavirus infection is binding of the viral spike protein, a 139-kDa protein, to certain receptors on host cells. The spike protein is the main surface antigen of the coronavirus. The glycosylated spike protein (as well as the nucleocapsid protein) can be detected in infected cell culture supernatants with antisera from SARS patients.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.